1Armstrong B & Doll R (1975) Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15, 617–631.
2Allen NE, Appleby PN, Davey GK & Key TJ (2000) Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer 83, 95–97.
3Gunnell D, Oliver SE, Peters TJ, et al. (2003) Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 88, 1682–1686.
4Thornburg T, Turner AR, Chen YQ, Vitolins M, Chang B & Xu J (2006) Phytanic acid, AMACR and prostate cancer risk. Future Oncol 2, 213–223.
5Wierzbicki AS, Lloyd MD, Schofield CJ, Feher MD & Gibberd FB (2002) Refsum's disease: a peroxisomal disorder affecting phytanic acid α-oxidation. J Neurochem 80, 727–735.
6Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, L'Esperance BS, Jiang Z & Ho SM (2003) Branched fatty acids in dairy and beef products markedly enhance α-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 12, 775–783.
7Xu J, Stolk JA, Zhang X, Silva SJ, Houghton RL, Matsumura M, Vedvick TS, Leslie KB, Badaro R & Reed SG (2000) Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 60, 1677–1682.
8Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J & Chu PG (2003) Expression of α-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases. Hum Pathol 34, 792–796.
9Jiang Z, Wu CL, Woda BA, et al. (2004) α-Methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology 45, 218–225.
10Luo J, Zha S, Gage WR, et al. (2002) α-Methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 62, 2220–2226.
11Nassar A, Amin MB, Sexton DG & Cohen C (2005) Utility of α-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem Mol Morphol 13, 252–255.
12Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D & Chinnaiyan AM (2002) α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287, 1662–1670.
13Witkiewicz AK, Varambally S, Shen R, Mehra R, Sabel MS, Ghosh D, Chinnaiyan AM, Rubin MA & Kleer CG (2005) α-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. Cancer Epidemiol Biomarkers Prev 14, 1418–1423.
14Zhou M, Chinnaiyan AM, Kleer CG, Lucas PC & Rubin MA (2002) α-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions. Am J Surg Pathol 26, 926–931.
15Body DR (1977) Characterization of bovine rumen liquor isoprenoid hydrocarbons with reference to dietary phytol. Lipids 12, 204–207.
16van den Brink DM & Wanders RJ (2006) Phytanic acid: production from phytol, its breakdown and role in human disease. Cell Mol Life Sci 63, 1752–1765.
17Riboli E & Kaaks R (1997) The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26, Suppl. 1, S6–S14.
18Davey GK, Spencer E, Appleby PN, Allen N, Knox K & Key TJ (2003) EPIC-Oxford: baseline characteristics and nutrient intakes in a cohort of 33,883 meat-eaters and 31,546 non meat-eaters in the UK. Public Health Nutr 6, 259–269.
19Holland B, Welch AA, Unwin ID, Buss DH, Paul AA & Southgate DAT (1991) McCance and Widdowson's The Composition of Foods, 5th ed.Cambridge, UK: Royal Society of Chemistry and Ministry of Agriculture, Fisheries and Food.
20Ministry of Agriculture Fisheries and Food (1993) Food Portion Sizes, 2nd ed.London: H.M. Stationery Office.
21Xu J, Thornburg T, Turner AR, et al. (2005) Serum levels of phytanic acid are associated with prostate cancer risk. Prostate 63, 209–214.
22Vreken P, van Lint AE, Bootsma AH, Overmars H, Wanders RJ & van Gennip AH (1998) Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry. J Chromatogr B Biomed Sci Appl 713, 281–287.
23ten Brink HJ, Stellaard F, van den Heuvel CM, Kok RM, Schor DS, Wanders RJ & Jakobs C (1992) Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography. J Lipid Res 33, 41–47.
24Office for National Statistics (2003) The National Diet and Nutrition Survey: Adults Aged 19 to 64 Years. Volume 2: Energy, Protein, Carbohydrate, Fat and Alcohol Intake. London: H.M. Stationery Office. http://www.food.gov.uk/multimedia/pdfs/ndnsv2.pdf.
25Bingham SA, Gill C, Welch A, et al. (1997) Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 26, Suppl. 1, S137–S151.
26Smedman AE, Gustafsson IB, Berglund LG & Vessby BO (1999) Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 69, 22–29.
27Wolk A, Vessby B, Ljung H & Barrefors P (1998) Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 68, 291–295.
28Wolk A, Furuheim M & Vessby B (2001) Fatty acid composition of adipose tissue and serum lipids are valid biological markers of dairy fat intake in men. J Nutr 131, 828–833.
29Brevik A, Veierod MB, Drevon CA & Andersen LF (2005) Evaluation of the odd fatty acids 15:0 and 17:0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur J Clin Nutr 59, 1417–1422.
30Wu Z & Palmquist DL (1991) Synthesis and biohydrogenation of fatty acids by ruminal microorganisms in vitro. J Dairy Sci 74, 3035–3046.
31Kumar-Sinha C, Shah RB, Laxman B, et al. (2004) Elevated α-methylacyl-CoA racemase enzymatic activity in prostate cancer. Am J Pathol 164, 787–793.
32Zha S, Ferdinandusse S, Denis S, Wanders RJ, Ewing CM, Luo J, De Marzo AM & Isaacs WB (2003) α-Methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Cancer Res 63, 7365–7376.
33Zheng SL, Chang BL, Faith DA, et al. (2002) Sequence variants of α-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 62, 6485–6488.